Trial intelligence / Profile preview

Magnesium Sulphate in COPD Patients Undergoing Larynx Surgery

NCT03461328Phase 4Completed

Sponsor
Cairo University
Start
Apr 2018
Primary completion
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of magnesium sulfate in chronic obstructive pulmonary disease (COPD), sponsored by Cairo University. Started Apr 2018; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT03461328.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03461328.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call